CVS Health Corp [CVS] stock is trading at $65.75, up 1.40%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CVS shares have gain 0.77% over the last week, with a monthly amount glided 19.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on February 13, 2025, when Leerink Partners upgraded its rating to a Outperform and also boosted its price target to $75 from $55. Previously, Cantor Fitzgerald upgraded its rating to Overweight on February 12, 2025. On January 30, 2025, upgrade upgraded it’s rating to Buy. Deutsche Bank upgraded its rating to a Buy but stick to its price target of $66 on December 03, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $66 on November 18, 2024. Barclays upgraded its rating to Overweight for this stock on October 10, 2024, and upped its price target to $82. In a note dated October 04, 2024, TD Cowen upgraded an Buy rating on this stock and boosted its target price from $59 to $85.
CVS Health Corp [CVS] stock has fluctuated between $43.56 and $80.75 over the past year. Currently, Wall Street analysts expect the stock to reach $72.14 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $65.75 at the most recent close of the market. An investor can expect a potential return of 9.72% based on the average CVS price forecast.
Analyzing the CVS fundamentals
CVS Health Corp [NYSE:CVS] reported sales of 372.69B for the trailing twelve months, which represents a growth of 3.77%. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.06 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.42 points at the first support level, and at 63.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 67.06, and for the 2nd resistance point, it is at 68.37.
Ratios To Look Out For
For context, CVS Health Corp’s Current Ratio is 0.81. Also, the Quick Ratio is 0.60, while the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.22, the price to book ratio is 1.10 and price to earnings (TTM) ratio is 17.98.
Transactions by insiders
Recent insider trading involved Clark James David, SVP, Cont & Chief Acct Officer, that happened on Mar 05 ’25 when 7513.0 shares were sold. Officer, Clark James David completed a deal on Mar 05 ’25 to buy 7513.0 shares. Meanwhile, Director Mahoney Michael F bought 30000.0 shares on Feb 18 ’25.
